DXR Daxor Corp.

Daxor to Present at the 2020 MicroCap Rodeo Best Ideas Bowl

Daxor to Present at the 2020 MicroCap Rodeo Best Ideas Bowl
EN
12/10/2020

Underlying

DXRDaxor Corp.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Daxor Corp.

 PRESS RELEASE
Free
DXR DAXOR CORP.

Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Gro...

Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit Summit Features a Select Group of 40 Promising Healthcare Companies at Premier Small-Cap Investor Event OAK RIDGE, TN, Oct. 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that President and Chief Executive Officer Michael Feldschuh will engage institutional investors at the Maxim Growth Summit presented by Maxim Group LLC. The Summit is being held on October 22 – 23, 2025, at the Hard Rock Hotel in New York City. Mr. Feldschuh will be a...

October 21, 2025 1 EN
 PRESS RELEASE
Free
DXR DAXOR CORP.

Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum F...

Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25 OAK RIDGE, Tenn., Oct. 15, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the MedAxiom Cardiovascular (CV) Transforum Fall’25 Conference being held at the JW Marriott Austin, from Thursday, October 16 - Saturday, October 18 in Austin, TX. The CV Transforum is the leading conference for cardiovascular organizational performance solutions, uniting industry innovators and thought leaders from across the country. “We are th...

October 15, 2025 1 EN
 PRESS RELEASE
Free
DXR DAXOR CORP.

Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand a...

Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA Three Studies Validate BVA-Guided Care Significantly Cuts Hospital Readmissions and Boosts Survival in High-Cost Heart Failure Segments OAK RIDGE, TN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces significant commercial momentum and clinical validation following the Heart Failure Society of America (HFSA) Annual Scientific Meeting. The company’s successful debut of its newly FDA-cleared, next-generation BVA a...

September 30, 2025 1 EN
 PRESS RELEASE
Free
DXR DAXOR CORP.

Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA A...

Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting Additional New Clinical Data To Be Presented Driving a New Standard of Care in Volume Measurement OAK RIDGE, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces it will exhibit at the Heart Failure Society of America (HFSA) Annual Scientific Meeting in Minneapolis, Minnesota, from September 26-29, 2025. The company will debut its newly FDA-cleared, next-generation blood volume analyzer (BVA), signaling a ...

September 23, 2025 1 EN
 PRESS RELEASE
Free
DXR DAXOR CORP.

Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients ...

Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care Study Demonstrates That Clinical Assessments of Fluid Status Are Often Inaccurate, Highlighting the Urgent Need for BVA and Other More Reliable Tools in Landmark Pilot Study Oak Ridge, TN, Sept. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today highlighted the significant findings of a new pilot study published in the Journal of Critical Care. Co-authored by leading intensive care expert...

September 4, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch